Andrea R. Hagemann

Also affiliated with Washington University in St. Louis, Cancer Research Center, Woman's Cancer Foundation

MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 22 papers. Top paper: “OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer”.

OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.578

N/A

0.399DataRank · unranked

12 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Mark S. Reed, Melanie K Bergman +21 more

A deficit-accumulation frailty index predicts survival outcomes in patients with gynecologic malignancy

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.02.027

N/A

0DataRank · unranked

15 citations

Tyler McKinnish, Mark A. Fiala, Abigail Zamorano, Lindsay M. Kuroki, Katherine C. Fuh +7 more

Impact of employment and insurance status on distress in gynecologic oncology patients

Gynecologic Oncology(2021)10.1016/j.ygyno.2021.01.038

N/A

0DataRank · unranked

10 citations

David H. Morris, Molly M. Greenwade, Megan Landon, Andrea R. Hagemann, Premal H. Thaker +8 more

Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer

Cancers(2021)10.3390/cancers13235877

N/A

0DataRank · unranked

7 citations

Elena Lomonosova, Shaina F. Bruce, Joan Tankou, Mary M. Mullen, Angela M. Schab +12 more

Radiation therapy for vaginal and perirectal lesions in recurrent ovarian cancer

Gynecologic Oncology Reports(2021)10.1016/j.gore.2021.100808

N/A

0DataRank · unranked

3 citations

Jennifer Stanley, Michael Toboni, Julie K. Schwarz, F. Zhang, Andrea R. Hagemann +8 more

GAS6-AXL Inhibition by AVB-500 Overcomes Resistance to Paclitaxel in Endometrial Cancer by Decreasing Tumor Cell Glycolysis

Molecular Cancer Therapeutics(2022)10.1158/1535-7163.mct-21-0704

N/A

0DataRank · unranked

16 citations

Kevin Cho, Hollie Noia, Elena Lomonosova, Elizabeth Stock, Alyssa Oplt +13 more

High visceral fat to subcutaneous fat ratios portend a poor prognosis in patients with advanced endometrial cancer

Gynecologic Oncology(2022)10.1016/j.ygyno.2022.09.011

N/A

0DataRank · unranked

12 citations

Mary M. Mullen, Rehan Nizamuddin, Jonathan H. Stein, Lindsay M. Kuroki, Katherine C. Fuh +8 more

Quantification of ovarian lesion and fallopian tube vasculature using optical-resolution photoacoustic microscopy

Scientific Reports(2022)10.1038/s41598-022-19778-1

N/A

0DataRank · unranked

7 citations

Sitai Kou, Yixiao Lin, Andrea R. Hagemann, Ian S. Hagemann, Premal H. Thaker +7 more

Gynecologic oncology patient perspectives and knowledge on advance care planning: A quality improvement intervention

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101060

N/A

0DataRank · unranked

3 citations

Sophia Lewis, Mark C. Valentine, M. Palisoul, Premal H. Thaker, Andrea R. Hagemann +6 more

Community access to primary care is an important geographic disparity among ovarian cancer patients undergoing cytoreductive surgery

Gynecologic Oncology Reports(2022)10.1016/j.gore.2022.101075

N/A

0DataRank · unranked

1 citations

Angela L. Mazul, Christine Marx, Mary M. Mullen, Molly M. Greenwade, L. Stewart Massad +9 more

RAD51 Foci as a Biomarker Predictive of Platinum Chemotherapy Response in Ovarian Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-3335

N/A

0DataRank · unranked

65 citations

Lillian N. van Biljon, Mark C. Valentine, Alba Llop‐Guevara, Emily Graham, Bisiayo Fashemi +18 more

Stromal DDR2 Promotes Ovarian Cancer Metastasis through Regulation of Metabolism and Secretion of Extracellular Matrix Proteins

Molecular Cancer Research(2023)10.1158/1541-7786.mcr-23-0347

N/A

0DataRank · unranked

22 citations

Molly M. Greenwade, Elizabeth Stock, Elena Lomonosova, Kevin Cho, Whitney R. Grither +17 more

Characterization of adnexal lesions using photoacoustic imaging to improve sonographic O‐RADS risk assessment

Ultrasound in Obstetrics and Gynecology(2023)10.1002/uog.27452

N/A

0DataRank · unranked

3 citations

Hongbo Luo, William D. Middleton, Malak Itani, Ian S. Hagemann, Andrea R. Hagemann +8 more

Enhancing Progestin Therapy with a Glucagon-Like Peptide 1 Agonist for the Conservative Management of Endometrial Cancer

Cancers(2025)10.3390/cancers17040598

N/A

0DataRank · unranked

14 citations

Ian S. Hagemann, David G. Mutch, Eric J. Devor, Paige K. Malmrose, Yuping Zhang +4 more

Phospho-RPA2 predicts response to platinum and PARP inhibitors in homologous recombination–proficient ovarian cancer

Journal of Clinical Investigation(2025)10.1172/jci189511

N/A

0DataRank · unranked

7 citations

Amanda Compadre, Rebecca Drexler, Megan Loeb, Kevin Rodriguez, Joshua Brill +22 more

A randomized phase II/III study of paclitaxel/carboplatin/metformin versus paclitaxel/carboplatin/placebo as initial therapy for measurable stage III or IVA, stage IVB, or recurrent endometrial cancer: An NRG oncology/GOG study

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.03.003

N/A

0DataRank · unranked

9 citations

Michael W. Sill, Paola A. Gehrig, Jason D. Merker, David L. Corcoran, Adam D. Pfefferle +15 more

Vascular graph network for ovarian lesion classification using optical-resolution photoacoustic microscopy

Photoacoustics(2025)10.1016/j.pacs.2025.100794

N/A

0DataRank · unranked

2 citations

L. Wang, Ian S. Hagemann, Lindsay M. Kuroki, Brooke E. Sanders, Andrea R. Hagemann +4 more

Molecular Profiling and Tumor Biomarker Analysis of GOG281/LOGS: A Positive Late-Phase Trial of Trametinib for Recurrent/Persistent Low-Grade Serous Ovarian Carcinoma

Clinical Cancer Research(2025)10.1158/1078-0432.ccr-25-3042

N/A

0DataRank · unranked

2 citations

Austin Miller, Heather A. Lankes, Kwong‐Kwok Wong, William H. Rodgers, David Millan +20 more

105P Immune biomarker analysis of the OVATION-2 trial, a randomized phase I/II study of IL-12 gene therapy IMNN-001 in combination with neo/adjuvant chemotherapy (NACT) in newly-diagnosed advanced epithelial ovarian cancer (EOC)

ESMO Open(2025)10.1016/j.esmoop.2025.105233

N/A

0DataRank · unranked

1 citations

Debra L. Richardson, Andrea R. Hagemann, Robert W. Holloway, Bhavana Pothuri, Jennifer Scalici +14 more

Integration of a lifestyle modification intervention for women with overweight and obesity in a gynecologic oncology practice

Gynecologic Oncology(2025)10.1016/j.ygyno.2025.04.516

N/A

0DataRank · unranked

4 citations

Alison Kosmacki, Leah Tolby, Christine Marx, Jessica Vanderlan, David G. Mutch +3 more

Effect on response to neoadjuvant chemotherapy in high-grade serous ovarian cancer by inhibiting the GAS6/AXL pathway and inducing homologous recombination deficiency.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6080

N/A

0DataRank · unranked

0 citations

Elena Lomonosova, Michael Toboni, Hollie Noia, Danny Wilke, Alyssa Oplt +9 more

Targeting RAD52 overcomes PARP inhibitor resistance in preclinical Brca2 -deficient ovarian cancer model

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.09.24.678351

N/A

0DataRank · unranked

0 citations

Vijayalaxmi Gupta, Bisiayo Fashemi, Moreniola Akande, Elizabeth Babu, Prasanth Thuthika +17 more